Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Digestive Diseases

• Publication date

  2016-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1159/000447275PMID 27548720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.

  2018cited by this paper
• Gut Microbiome : Its Relationship to Health and Its Modulation by Diet

  2017cited by this paper
• MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease.

  2016cited by this paper
• Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease

  2015cited by this paper
• Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

  2015cited by this paper
• Nonalcoholic fatty liver disease: a systematic review.

  2015cited by this paper
• Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease

  2015cited by this paper
• Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

  2015cited by this paper
• Gut microbiome and nonalcoholic fatty liver diseases

  2015cited by this paper
• Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice

  2015cited by this paper
• Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.

  2015cited by this paper
• Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.

  2015cited by this paper
• Weight Loss for a Healthy Liver.

  2015cited by this paper
• Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans

  2014cited by this paper
• Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

  2014cited by this paper
• Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice

  2014cited by this paper
• Bile acid receptors as targets for drug development

  2014cited by this paper
• Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.

  2013cited by this paper
• PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease

  2013cited by this paper
• Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

  2013cited by this paper
• Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

  2013cited by this paper
• Intestinal microbiota in patients with nonalcoholic fatty liver disease

  2013cited by this paper
• Dietary fructose in nonalcoholic fatty liver disease

  2013cited by this paper
• Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.

  2013cited by this paper
• 1360 PNPLA3 GG GENOTYPE IS ASSOCIATED WITH CAROTID ATHEROSCLEROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

  2013cited by this paper
• Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects

  2012cited by this paper
• IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.

  2012cited by this paper
• Apoptotic cell death and efferocytosis in atherosclerosis.

  2012cited by this paper
• High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism

  2012cited by this paper
• Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits

  2011cited by this paper
• Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans.

  2011cited by this paper
• Ceramides as modulators of cellular and whole-body metabolism.

  2011cited by this paper
• DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.

  2011cited by this paper
• Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans.

  2011cited by this paper
• Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency.

  2011cited by this paper
• The role of the gut microbiota in nonalcoholic fatty liver disease

  2010cited by this paper
• PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease

  2010cited by this paper
• Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance

  2010cited by this paper
• Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

  2010cited by this paper
• Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.

  2010cited by this paper
• Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children

  2010cited by this paper
• Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.

  2010cited by this paper
• Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

  2010cited by this paper
• Elevated endotoxin levels in non-alcoholic fatty liver disease

  2010cited by this paper
• Sphingolipids: players in the pathology of metabolic disease.

  2009cited by this paper
• Genetic variation in PNPLA 3 confers susceptibility to nonalcoholic fatty liver disease

  2009cited by this paper
• Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

  2009cited by this paper
• Glucokinase and molecular aspects of liver glycogen metabolism.

  2008cited by this paper
• Hepatotoxicity of fast food?

  2008cited by this paper
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

  2008cited by this paper
• Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men

  2006cited by this paper
• Inflammation and metabolic disorders

  2006cited by this paper
• Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

  2006cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006cited by this paper
• A low‐carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content

  2006cited by this paper
• Dietary fat content modifies liver fat in overweight nondiabetic subjects.

  2005cited by this paper
• Insulin resistance: A metabolic pathway to chronic liver disease

  2005cited by this paper
• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

  2005cited by this paper
• Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.

  2005cited by this paper
• Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

  2004cited by this paper
• Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance.

  2003cited by this paper

• Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances

  2024cites this paper
• The Effect of Giving Salak (Salacca Zalacca) Bark Extract on Liver Function and Histopathological Features of the Liver of Male Wistar White Rats Obesity Model

  2024cites this paper
• Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review

  2024cites this paper
• Vinpocetine and Lactobacillus improve fatty liver in rats: role of adiponectin and gut microbiome

  2024cites this paper
• The Role of Gut Microbiota in Non-alcoholic Fatty Liver Disease Pathogenesis

  2024cites this paper
• Vinpocetine and Lactobacillus improve fatty liver in rats via modulating the oxidative stress, inflammation, adiponectin and gut microbiome.

  2023cites this paper
• Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis

  2023cites this paper
• Bidirectional Regulation of Sodium Acetate on Macrophage Activity and Its Role in Lipid Metabolism of Hepatocytes

  2023cites this paper
• Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota

  2023cites this paper
• Significant roles of potential genes and their mutations in nonalcoholic fatty liver disease

  2023cites this paper
• Are fructophilic lactic acid bacteria (FLAB) beneficial to humans?

  2022cites this paper
• Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome.

  2022cites this paper
• Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis

  2022cites this paper
• Phospholipids in non-alcoholic fatty liver disease

  2022cites this paper
• İn Vitro Lipopolisakkarit Uyarımlı Karaciğer Yangı Modelinde Alfa-Terpineol’ün Etkinliğinin Araştırılması

  2022cites this paper
• SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease

  2022cites this paper
• Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease

  2021cites this paper
• Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

  2021cites this paper
• On the Relationship Between Non-alcoholic Fatty Liver Disease with Body Composition and Bone Mineral Density in Overweight/Obese Adolescents

  2021cites this paper
• Sodium Acetate Inhibit TGF-β1-Induced Activation of Hepatic Stellate Cells by Restoring AMPK or c-Jun Signaling

  2021cites this paper
• Non-alcoholic fatty liver disease: A patient guideline

  2021influential citation
• Fatty liver in pregnancy: a narrative review of two distinct conditions

  2020cites this paper
• A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?

  2020cites this paper
• Gut microbiome, endocrine control of gut barrier function and metabolic diseases.

  2020cites this paper
• Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease

  2020cites this paper
• Obesity and NAFLD: Same Problem?

  2020cites this paper
• Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges

  2019cites this paper
• The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms

  2019influential citation
• Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease

  2019cites this paper
• HEPATOCYTES' FUNCTION AND ADIPOKINES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE ACE (rs4646994) AND PPAR-2 (rs1801282) GENES' POLYMORPHISMS

  2018cites this paper
• Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics

  2018cites this paper
• Liver Fat Content and Body Fat Distribution in Youths with Excess Adiposity

  2018cites this paper
• Metabolic Syndrome Is Associated with Health-Related Quality of Life in Suspected Patients with Nonalcoholic Steatohepatitis

  2018cites this paper
• Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease

  2017cites this paper
• Serum fatty acid profile in psoriasis and its comorbidity

  2017cites this paper
• Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment

  2017cites this paper
• Serum alkaline phosphatase, a risk factor for non-alcoholic fatty liver, but only for women in their 30s and 40s: evidence from a large cohort study

  2017cites this paper
• Parasites, microbiota and metabolic disease

  2017cites this paper
• Massa Medicata Fermentata improves fatty liver in high fat diet-fed nonalcoholic fatty liver disease's mouse model

  2014cites this paper
• Journal of Pharmaceutical Research and Clinical Practice

  year unknowncites this paper